Figure 1.
Figure 1. Progression-Free Survival by Patient Subgroup, Galiximab Clinical Study Solid line represents the hazard ratio observed in the primary analysis.

Progression-Free Survival by Patient Subgroup, Galiximab Clinical Study Solid line represents the hazard ratio observed in the primary analysis.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal